688393.SH
Guangzhou LBP Medicine Science & Technology Co., Ltd.
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 19.04
+3.53%Oct 12, 2026, 12:02 UTC
Anbio Biotechnology and its subsidiaries said they obtained three intellectual-property qualifications during July–September 2026: one invention patent and two utility-model patents.
Source:Oct 12, 2026, 12:02 UTC
Anbio Biotechnology and its subsidiaries said they obtained 19 domestic Class I medical-device filing certificates and one overseas CE registration for sample preservation solution during July–September 2026.
Source:Sep 9, 2026, 14:03 UTC
On September 9, 2026, ten A-share listed companies including Wisdom, Rongxin Culture, Dison, Haichuan Intelligent, Lvyin Ecology, Huang Shang Huang, Anbiping, Zhongzhong Technology, Yazhen Home Furnishing, and Bide Pharmaceutical disclosed plans to reduce their shareholdings, while Tiandi Technology disclosed plans to increase its shareholding.
Source:Aug 27, 2026, 09:10 UTC
Anbiping announced its first-half 2026 results: revenue of 172 million yuan, up 7.60% year-on-year; net profit attributable to shareholders of 764,900 yuan, up 106.12%; non-recurring net loss of 680,500 yuan, narrowing by 95.37%; basic EPS of 0.01 yuan per share, up 107.69%.
Source: